Senvest Management LLC Sells 2,203,627 Shares of UiPath, Inc. $PATH

Senvest Management LLC reduced its holdings in shares of UiPath, Inc. (NYSE:PATHFree Report) by 18.2% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,892,856 shares of the company’s stock after selling 2,203,627 shares during the period. UiPath comprises about 4.2% of Senvest Management LLC’s investment portfolio, making the stock its 9th biggest position. Senvest Management LLC’s holdings in UiPath were worth $126,629,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the business. AdvisorNet Financial Inc grew its stake in shares of UiPath by 320.4% in the 2nd quarter. AdvisorNet Financial Inc now owns 2,476 shares of the company’s stock valued at $32,000 after purchasing an additional 1,887 shares during the period. GAMMA Investing LLC grew its position in UiPath by 48.0% in the second quarter. GAMMA Investing LLC now owns 2,989 shares of the company’s stock valued at $38,000 after acquiring an additional 969 shares during the period. IFP Advisors Inc raised its stake in UiPath by 508.0% during the second quarter. IFP Advisors Inc now owns 3,283 shares of the company’s stock worth $42,000 after acquiring an additional 2,743 shares in the last quarter. Bayforest Capital Ltd raised its stake in UiPath by 852.4% during the second quarter. Bayforest Capital Ltd now owns 4,143 shares of the company’s stock worth $53,000 after acquiring an additional 3,708 shares in the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in shares of UiPath in the 2nd quarter valued at $55,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

Insider Buying and Selling at UiPath

In other news, CAO Hitesh Ramani sold 5,000 shares of the company’s stock in a transaction dated Wednesday, October 22nd. The stock was sold at an average price of $15.47, for a total value of $77,350.00. Following the completion of the sale, the chief accounting officer directly owned 182,776 shares of the company’s stock, valued at $2,827,544.72. This represents a 2.66% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Daniel Dines sold 45,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $15.07, for a total transaction of $678,150.00. Following the completion of the sale, the chief executive officer directly owned 29,288,585 shares of the company’s stock, valued at $441,378,975.95. The trade was a 0.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 2,319,002 shares of company stock valued at $34,094,875 in the last quarter. Corporate insiders own 23.19% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on PATH. DA Davidson started coverage on shares of UiPath in a research note on Friday, September 5th. They set a “neutral” rating and a $12.00 price objective on the stock. BMO Capital Markets lifted their price objective on UiPath from $12.50 to $13.00 and gave the company a “market perform” rating in a research report on Thursday, October 2nd. UBS Group set a $17.00 target price on UiPath and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Weiss Ratings reiterated a “sell (d+)” rating on shares of UiPath in a research report on Thursday, October 30th. Finally, Needham & Company LLC restated a “hold” rating on shares of UiPath in a research report on Friday, September 5th. Two research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $13.71.

Read Our Latest Research Report on UiPath

UiPath Stock Down 3.4%

Shares of PATH stock opened at $13.55 on Tuesday. The firm has a market cap of $7.20 billion, a price-to-earnings ratio of 451.70, a PEG ratio of 5.19 and a beta of 1.09. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $18.74. The stock has a 50-day moving average price of $14.26 and a 200 day moving average price of $12.89.

UiPath (NYSE:PATHGet Free Report) last issued its earnings results on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.07. UiPath had a net margin of 1.35% and a return on equity of 1.28%. The company had revenue of $361.73 million for the quarter, compared to analyst estimates of $347.36 million. During the same quarter last year, the firm earned $0.04 EPS. The company’s revenue for the quarter was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Sell-side analysts predict that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Featured Stories

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATHFree Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.